ATA373379A - Verfahren zur herstellung von neuen 5-substituier-ten hydantoinen - Google Patents

Verfahren zur herstellung von neuen 5-substituier-ten hydantoinen

Info

Publication number
ATA373379A
ATA373379A AT0373379A AT373379A ATA373379A AT A373379 A ATA373379 A AT A373379A AT 0373379 A AT0373379 A AT 0373379A AT 373379 A AT373379 A AT 373379A AT A373379 A ATA373379 A AT A373379A
Authority
AT
Austria
Prior art keywords
producing new
substituted hydantoins
hydantoins
substituted
producing
Prior art date
Application number
AT0373379A
Other languages
English (en)
Other versions
AT366034B (de
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Priority to AT0551580A priority Critical patent/AT366035B/de
Publication of ATA373379A publication Critical patent/ATA373379A/de
Application granted granted Critical
Publication of AT366034B publication Critical patent/AT366034B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT0373379A 1978-05-23 1979-05-21 Verfahren zur herstellung von neuen 5-substituier-ten hydantoinen AT366034B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0551580A AT366035B (de) 1978-05-23 1980-11-10 Verfahren zur herstellung von neuen 5-substituier-ten hydantoinen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21352/78A GB1601310A (en) 1978-05-23 1978-05-23 Aryl hydantoins

Publications (2)

Publication Number Publication Date
ATA373379A true ATA373379A (de) 1981-07-15
AT366034B AT366034B (de) 1982-03-10

Family

ID=10161451

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0373379A AT366034B (de) 1978-05-23 1979-05-21 Verfahren zur herstellung von neuen 5-substituier-ten hydantoinen

Country Status (31)

Country Link
US (2) US4241073A (de)
EP (1) EP0005647B1 (de)
JP (1) JPS54160373A (de)
KR (1) KR830000635B1 (de)
AR (2) AR225143A1 (de)
AT (1) AT366034B (de)
AU (1) AU530968B2 (de)
BE (1) BE876435A (de)
BG (2) BG31799A3 (de)
CA (1) CA1120481A (de)
CH (2) CH639650A5 (de)
CS (2) CS208654B2 (de)
DD (1) DD143769A5 (de)
DE (1) DE2963061D1 (de)
DK (1) DK207579A (de)
ES (1) ES480850A1 (de)
FI (1) FI791614A (de)
FR (1) FR2426681A1 (de)
GB (1) GB1601310A (de)
GR (1) GR68363B (de)
HU (1) HU184648B (de)
IL (1) IL57343A (de)
LU (1) LU81300A1 (de)
MX (1) MX5604E (de)
NZ (1) NZ190512A (de)
PL (2) PL119612B1 (de)
PT (1) PT69648A (de)
RO (2) RO76807A (de)
SU (2) SU873878A3 (de)
YU (1) YU120179A (de)
ZA (1) ZA792501B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013647C2 (de) * 1980-04-09 1985-07-11 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von 5-Arylidenhydantoinen (B)
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JPS6317864A (ja) * 1986-07-11 1988-01-25 Mitsui Toatsu Chem Inc ヒダントイン類の製造方法
HU204047B (en) * 1987-01-31 1991-11-28 Sandoz Ag Process for producing pilocarpine derivatives and pharmaceutical compositions comprising such compounds
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
PT97507B (pt) * 1990-04-27 1998-08-31 Orion Yhtymae Oy Processo para apreparacao de novos derivados de catecol farmacologicamente activos
FR2687153B1 (fr) * 1992-02-07 1994-05-13 Hoechst Ste Francaise Procede de preparation de la (thenyl-2)-5 hydantouine.
WO1995029910A1 (en) * 1994-04-28 1995-11-09 Yamanouchi Pharmaceutical Co., Ltd. Imidazolidinedione derivative
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
NZ532909A (en) * 2001-11-30 2006-08-31 Lilly Co Eli Peroxisome proliferator activated receptor agonists
SE0202539D0 (sv) * 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
FR2845000B1 (fr) * 2002-09-27 2005-05-27 Oreal Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
EP2155692B1 (de) * 2007-05-30 2015-06-17 F. Hoffmann-La Roche AG Nicht-nukleosidische reverse-transkriptase-hemmer
CN101990534A (zh) * 2007-11-01 2011-03-23 Uab研究基金会 治疗和预防病毒感染
GB2463514C (en) * 2008-09-11 2018-09-26 Galapagos Nv Imidazolidine compounds and uses therefor
ITBO20090078A1 (it) * 2009-02-13 2010-08-14 Consiglio Nazionale Ricerche Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR910275A (fr) * 1944-11-14 1946-06-03 Nouvelles hydantoïnes et leur procédé de préparation
US2479065A (en) * 1945-09-06 1949-08-16 Du Pont Preparation of 5-benzylhydantoin
US2861079A (en) * 1956-06-04 1958-11-18 Dow Chemical Co Process for making unsaturated hydantoins
GB846601A (en) * 1958-01-13 1960-08-31 British Oxygen Res And Dev Ltd Vinyl hydantoins
US3365296A (en) * 1964-05-18 1968-01-23 Gen Aniline & Film Corp Light-sensitive ultraviolet absorbing compounds and diazotype materials containing the same
US3395153A (en) * 1964-12-16 1968-07-30 United States Borax Chem 3, 5-dialkylhydantoins
US3847933A (en) * 1970-12-09 1974-11-12 Exxon Research Engineering Co Acid catalyzed alkylation of hydantoin
JPS5136332B1 (de) * 1970-12-09 1976-10-07
US3932449A (en) * 1973-10-09 1976-01-13 Morton-Norwich Products, Inc. 5-(P-dimethylaminobenzyl) hydantoin
GB1575904A (en) * 1976-04-23 1980-10-01 Lilly Industries Ltd Phenyl piperazines
JPS54122276A (en) * 1978-03-15 1979-09-21 Kanegafuchi Chem Ind Co Ltd Preparation of 5-(2-thienyl) hydantion

Also Published As

Publication number Publication date
CS208653B2 (en) 1981-09-15
DD143769A5 (de) 1980-09-10
LU81300A1 (fr) 1980-12-16
BG32115A4 (en) 1982-05-14
AT366034B (de) 1982-03-10
FR2426681A1 (fr) 1979-12-21
YU120179A (en) 1983-02-28
SU988190A3 (ru) 1983-01-07
PL119612B1 (en) 1982-01-30
RO76807A (ro) 1981-04-26
PL222701A1 (de) 1980-12-15
AU4728979A (en) 1979-11-29
FI791614A (fi) 1979-11-24
US4241073A (en) 1980-12-23
AU530968B2 (en) 1983-08-04
JPS54160373A (en) 1979-12-19
CS208654B2 (en) 1981-09-15
BG31799A3 (en) 1982-03-15
PL125075B1 (en) 1983-03-31
GB1601310A (en) 1981-10-28
CH643546A5 (fr) 1984-06-15
PL215773A1 (de) 1980-07-14
AR224186A1 (es) 1981-10-30
KR830000635B1 (ko) 1983-03-23
DK207579A (da) 1979-11-24
PT69648A (en) 1979-06-01
IL57343A (en) 1982-09-30
RO79703A (ro) 1982-08-17
NZ190512A (en) 1984-10-19
CA1120481A (en) 1982-03-23
HU184648B (en) 1984-09-28
MX5604E (es) 1983-11-07
EP0005647B1 (de) 1982-06-09
US4293563A (en) 1981-10-06
AR225143A1 (es) 1982-02-26
FR2426681B1 (de) 1983-08-12
DE2963061D1 (en) 1982-07-29
EP0005647A1 (de) 1979-11-28
GR68363B (de) 1981-12-23
ES480850A1 (es) 1980-02-01
CH639650A5 (fr) 1983-11-30
IL57343A0 (en) 1979-09-30
BE876435A (fr) 1979-11-21
SU873878A3 (ru) 1981-10-15
ZA792501B (en) 1980-05-28

Similar Documents

Publication Publication Date Title
AT366034B (de) Verfahren zur herstellung von neuen 5-substituier-ten hydantoinen
AT369743B (de) Verfahren zur herstellung von neuen penemverbindungen
AT366689B (de) Verfahren zur herstellung von neuen spirooxazolidindionen
ATA590580A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT376684B (de) Verfahren zur herstellung von neuen bor-silicium- verbindungen
AT364097B (de) Verfahren zur herstellung von neuen bicyclooctanderivaten
AT375927B (de) Verfahren zur herstellung von neuen imidazolderivaten
AT366365B (de) Verfahren zur herstellung von neuen 4-nitro-2trichlormethylphenyldisulfiden
AT362789B (de) Verfahren zur herstellung von neuen n-aryl-1,3oxazolidin-2,4-dionen
AT369377B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT367397B (de) Verfahren zur herstellung von neuen n-phenaethyl- glycinamiden
AT362872B (de) Verfahren zur herstellung von neuen demethylmaytansinoiden
ATA291979A (de) Verfahren zur herstellung von neuen ver- bindungen
AT368516B (de) Verfahren zur herstellung von neuen nitrosoharnstoff-verbindungen
AT364347B (de) Verfahren zur herstellung von neuen 1beta-hydroxy-2beta-alkenyl-3-methylencyclopentan-4 beta-yl-cyclopropancarboxylaten
AT375647B (de) Verfahren zur herstellung von neuen wasserl
AT362067B (de) Verfahren zur herstellung von neuen deoxyanthracyclinen
AT368517B (de) Verfahren zur herstellung von neuen nitrosoharnstoffverbindungen
AT368159B (de) Verfahren zur herstellung von neuen beta-lactam -verbindungen
AT366035B (de) Verfahren zur herstellung von neuen 5-substituier-ten hydantoinen
AT371475B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT366698B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA831278A (de) Verfahren zur herstellung von neuen 3-di-n- -propyl-acetoxy-benzodiazepin-2-onen
ATA330681A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA246881A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee